Pregnancy and breastfeeding: No safety data
Unlike traditional medical trend drivers, such as hospital price increases or incremental pharmaceutical innovations, GLP-1 agonists combine rapid uptake, significant per-patient costs, and uncertain long-term offsets
However, under the Medicare GLP-1 Bridge program announced by CMS in December 2025, eligible Medicare Part D beneficiaries will be able to access Foundayo beginning July 1, 2026, for approximately $50 per month
Individual circumstances: While guidelines are in place, a doctor is ultimately responsible for making decisions appropriate for each patient
Conclusion Navigating the relationship between coffee consumption and glutathione supplementation requires a nuanced approach